Acción 2796 PHARMARISE HOLDINGS CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Pharmarise Holdings Corporation

Acciones

2796

JP3802320006

Diferido Japan Exchange
Otros sitios de cotización
 08:00:00 15/05/2024 		Varia. Cinco días. Varia. 1 de enero.
656 JPY -0,15 % Gráfico intradía de Pharmarise Holdings Corporation -0,15 % -0,61 %
11/04 El beneficio atribuible de Pharmarise Holdings baja un 15% en los nueve meses fiscales por los mayores gastos tras las fusiones y adquisiciones MT
10/04 Pharmarise Holdings Corporation revisa la previsión de beneficios consolidados para el ejercicio fiscal que finaliza el 31 de mayo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise
Pharmarise Holdings Corporation authorizes a Buyback Plan.
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 2796
  4. Noticias Pharmarise Holdings Corporation
  5. Otros idiomas